Search research articles
Contact Us
Filters
Showing results (11-20 of 61) with videos related to
Page
of 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2018
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T A Chan, M Yarchoan, E Jaffee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al
J García-Foncillas, D Arnold, B Avouac, et al.
Journal of Cellular and Molecular Medicine
|
November 18, 2008
The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma
P Koch, A Stenzinger, M Viard, et al.
Journal of Neuro-Oncology
|
April 12, 2015
PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor
M K Petri, A Brobeil, J Planz, et al.
Familial Cancer
|
November 4, 2025
Endoscopic papillectomy for ampullary adenomas in familial adenomatous polyposis
C Wehling, Y Eckstein, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2011
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
T Hristozova, R Konschak, C Stromberger, et al.
Der Pathologe
|
August 13, 2013
[Congratulations on your birthday, dear Mr. Dietel!]
C Denkert, A Erbersdobler, U Kellner, et al.
Histology and Histopathology
|
October 6, 2011
PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ
M K Petri, P Koch, A Stenzinger, et al.
Immuno-Oncology Technology
|
September 23, 2024
Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler
S Böning, F Schneider, A-K Huber, et al.
Oncogene
|
August 25, 2015
The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability
S Lüddecke, N Ertych, A Stenzinger, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 61) with videos related to
Sort By:
Page
of 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 6, 2018
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
T A Chan, M Yarchoan, E Jaffee, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al
J García-Foncillas, D Arnold, B Avouac, et al.
Journal of Cellular and Molecular Medicine
|
November 18, 2008
The novel protein PTPIP51 is expressed in human keratinocyte carcinomas and their surrounding stroma
P Koch, A Stenzinger, M Viard, et al.
Journal of Neuro-Oncology
|
April 12, 2015
PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor
M K Petri, A Brobeil, J Planz, et al.
Familial Cancer
|
November 4, 2025
Endoscopic papillectomy for ampullary adenomas in familial adenomatous polyposis
C Wehling, Y Eckstein, A Stenzinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2011
The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN)
T Hristozova, R Konschak, C Stromberger, et al.
Der Pathologe
|
August 13, 2013
[Congratulations on your birthday, dear Mr. Dietel!]
C Denkert, A Erbersdobler, U Kellner, et al.
Histology and Histopathology
|
October 6, 2011
PTPIP51, a positive modulator of the MAPK/Erk pathway, is upregulated in glioblastoma and interacts with 14-3-3β and PTP1B in situ
M K Petri, P Koch, A Stenzinger, et al.
Immuno-Oncology Technology
|
September 23, 2024
Region of interest localization, tissue storage time, and antibody binding density-a technical note on the GeoMx® Digital Spatial Profiler
S Böning, F Schneider, A-K Huber, et al.
Oncogene
|
August 25, 2015
The putative oncogene CEP72 inhibits the mitotic function of BRCA1 and induces chromosomal instability
S Lüddecke, N Ertych, A Stenzinger, et al.
Page
of 7